Pazopanib/Pazopanib (Pazopanib) indications

Pazopanib is indicated for the treatment of adults with advanced renal cell carcinoma (RCC). Pazopanib tablets are also indicated for the treatment of adult patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy. The efficacy of pazopanib tablets in patients with adipocytic STS or gastrointestinal stromal tumors has not been proven.

Pazopanib tablets are taken orally. Each 200mg pazopanib tablet contains 200mg of pazopanib, which is equivalent to 216.7mg of pazopanib hydrochloride. The inactive ingredients of pazopanib tablets are magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate. Coating:Gray film coating:Hydroxypropylcellulose, hydroxypropylmethylcellulose, iron oxide black, polyethylene glycol8000 and titanium dioxide. Pazopanib tablets are not intended for use in pediatric patients. Based on its mechanism of action, pazopanib may have serious effects on organ growth and maturation during early postnatal development. Pazopanib, administered to young rats less than 21 days old, caused toxicity to the lungs, liver, heart and kidneys and resulted in death at a dose that was significantly lower than the clinically recommended dose or the dose tolerated by older animals. Pazopanib tablets may cause serious adverse effects on the organ development of pediatric patients, especially those under the age of 2. The retail price of Bangladesh Yaopin International Pharmaceutical200mg30 tablets is about 600 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.